fda import alert 66-80 glp-1 api green list FDA's Green List: A Step in the Right Direction for Patient Safety-mvanhaasteren.nl FDA introduces "Green List" for

Feel good, stay full, and keep moving forward.

Over the last year, the Indian obesity-treatment market has changed very fast

And when youre on a GLP-1 receptor agonist, your nutritional strategy is more important than ever

The August 2023 announcement of topline results was followed in November 2023 by a presentation of detailed results7, which revealed a statistically significant reduction in non-fatal myocardial infarction of 28% and smaller reductions in cardiovascular death and non-fatal stroke which were not statistically significant over the length of the trial (up to five years)

Taking GLP-1s during the first trimester of pregnancy does not appear to increase the risk of major adverse outcomes such as non-live birth, according to a new Harvard Chan School study.

See what the science says before you buy.